Genotyping of FCGR2B–I232T, FCGR2A–H131R, FCGR3A–F176V, FCGR3B–NA1/2 and TNFR2–M196R polymorphisms were performed in 382 Japanese patients and 303 healthy individuals for FCGRs, and in 588 patients and 308 controls for TNFR2. Significant difference in the distribution of genotype, allele carrier and allele frequencies was not observed between patients with RA and healthy individuals in FCGR genes. However, when the subjects were stratified according to the carriage of HLA–DRB1 shared epitope (SE), significant increase of FCGR3A–176F/F genotype was observed in SE positive RA (55.9%) compared with SE positive controls (41.5%) (P = 0.009).
As for TNFR2, a tendency of increase of 196R/R genotype in RA (2.9%) compared with healthy individuals (1.0%) was observed (P = 0.07). However, estimation of genotype relative risk, which adjusts control data for Hardy–Weinberg equilibrium and has a higher power of detecting association, indicated that TNFR2–196R/R genotype was significantly increased in RA compared with controls (&khgr;2 = 6.2, P = 0.01, OR:2.3).
These results indicated that FCGR3A–176F/F genotype confers risk for RA through genetic interaction with HLA–DRB1 SE, and TNFR2–196R/R genotype may be a weak, but true, risk factor in the sporadic RA, in Japanese.